Clinical trial
Special Survey on Long-term Drug Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease
NCT01525641 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Survey on Long-term Drug Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- June 30, 2014
- Enrollment
- 615 (actual)
- Sites
- 118
Conditions
As the registry lists them; a condition with its own page is linked.